ABBVIE INC. (ABBV)
Clinical trial NCT06118411 updates: 1. completion date: 2028-02-01 → 2028-03-01 2. primary completion date: 2025-09-23 → 2028-03-01
Clinical trial NCT06118411 updates: 1. completion date: 2028-02-01 → 2028-03-01 2. primary completion date: 2025-09-23 → 2028-03-01
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical